Ser1084
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
Home | Login
About PhosphoSiteUsing PhosphoSiteprivacy & cookiesCuration ProcessContact
logos LINCs Logo Mt Sinai Logo NIH Logo NCI Logo
Search / Browse Functions
Phosphorylation Site Page:
Ser1084 - ITGB4 (human)

Site Information
RRFHVQLsNPKFGAH   SwissProt Entrez-Gene
Predicted information:  Scansite
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 3651980

In vivo Characterization
Methods used to characterize site in vivo: mass spectrometry (1, 2, 3)
Disease tissue studied: breast cancer (2), HER2 positive breast cancer (1), luminal A breast cancer (1), luminal B breast cancer (1), breast cancer, triple negative (1)
Relevant cell line - cell type - tissue: breast (1), HeLa (cervical) (3), MCF10A1 (epithelial) (2), MCF10AT1K (epithelial) (2), MCF10CA1a (epithelial) (2), MCF10CA1h (epithelial) (2)




References

1

Mertins P, et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55-62
27251275   Curated Info

2

Chen Y, et al. (2007) Differential expression of novel tyrosine kinase substrates during breast cancer development. Mol Cell Proteomics 6, 2072-87
17855441   Curated Info

3

Yu LR, et al. (2007) Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra. J Proteome Res 6, 4150-62
17924679   Curated Info

Home  |  Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2017 Cell Signaling Technology, Inc.